All pairs

Posaconazole and Lovastatin

Desk tier: Avoid together

Mechanism: strong CYP3A4 inhibition of clearance (↑ exposure)

“Coadministration with the HMG-CoA reductase inhibitors that are primarily metabolized through CYP3A4 (e.g., atorvastatin, lovastatin, and simvastatin) is contraindicated”
Noxafil (posaconazole), section 4 CONTRAINDICATIONS. DailyMed label

Open this pair in the desk

All pairs for Posaconazole · Lovastatin

Enzyme behind this pair: CYP3A4

Educational reference only. Not FDA-cleared. The Prescribing Information governs.